Conference Room

Workshop Room

Conference Room

Regulation, Legislation & The Role of Big Pharma

09:00-09:20

Conference Inauguration - Welcome Remarks

Joseph Cuschieri

09:20-09:30

Malta's Journey

What key drivers were behind the introduction of the production of cannabis for medicinal use act?

Hon. Miriam Dalli

09:40-10:00

The Use of Medical Cannabis for Autism Therapy

How is the endocannabinoid system connected to social reward responsivity, neural development, circadium rhythm and anxiety-related symptoms?

Mauro Maccarrone

10:00-10:20

Managing Fibromyalgia

What does the latest research say about managing symptoms of fibromyalgia with cannabis?

Piercarlo Sarzi-Puttini

10:20-10:40

WHO and its Impact on National Policies

International organisations such as the World Health Organisation are becoming increasingly vocal on the application of medical cannabis. How is this impacting policy makers at state-level across different continents?

Monty Munford

10:40-00:00

Pain Management

What is the appropriate use of medical cannabis for patients with chronic pain?

Silviu Brill

10:50-11:10

Emotional Memory Acquisition

The role of the endocannabinoid system as an emotional buffer for stressful memories.

Patrizia Campolongo

11:10-11:30

Alternative Options

The argument for boosting the body's natural endocannabinoids.

Giuseppe Di Giovanni

11:30-11:50

Pioneering WhiteSpace for Brands

How to utilize data-science to distil irrefutable human insights, highly differentiated brand narrative and brand creation in the rapidly evolving global medical cannabis landscape.

Anthony Wolch

11:50-12:00

Intellectual Property and its Challenges

How can pharmaceutical companies develop an effective intellectual property and commercial strategy for synthetic cannabinoids?

Gabriel Micallef

12:00-12:20

Synthetic Cannabinoids

what are the benefits and disadvantages of man-made cannabinoids?

Manit Patel

Neville Edel

12:20-12:30

Monitoring and Control

What steps are being taken towards standardisation and quality control on a European level?

Investment Opportunities & The Start-Up Pitch

14:00-14:10

Case Study

From concept to exit, review of a successful start-up investment.
14:10-14:30

Mergers & Acquisitions

As Big Tobacco and Big Alcohol get involved in the medical cannabis industry, how will this affect global markets?
14:30-14:40

Pick and Shovel Play

How are investors using this strategy to mitigate risk in volatile cannabis stocks?
14:40-14:50

ETFs

What's the advantages of entering the medical cannabis investment market via exchange traded funds?
14:50-15:00

Review

Which are the best medical cannabis stocks and what can future big players learn from them?
15:00-15:10

Economic Sectors

In which other ways does the production of medical cannabis benefit a country's other economic sectors?
15:10-15:30

Fund Restrictions

Depending on the type of funds they have access to, some investors cannot put capital into the cultivation of the crop, only technology and services that are not related to the plant itself. How is this restricting start-ups from getting the capital they need?
15:30-15:40

Mergers & Acquisitions

This is already a feature of the medical cannabis sector. How might it affect its future in Europe?
15:40-15:50

Emerging Markets

How does medical cannabis compare to other emerging markets?
15:50-16:00

Ancilliary Services

What sort of investment is required in ancillary services in order to support the medical cannabis sector?
16:00-16:20

From ICO's to Cannabis

Following the recent pitfall that many investors have experienced with ICO's worldwide, could cannabis pave the way for more secure investment opportunities?
16:20-16:30

Market Overview

What is the European medicinal cannabis market worth and what are the future projections?
16:30-16:40

Funding and Research

Both the public and private sector are investing in scientific research. How can the two work together for both the benefit of patients and future commercial success?
16:40-16:50

Mitigating Risk

Investment firms have highlighted several risk factors in investing in the European medical cannabis industry. How are these to be reduced?
16:50-17:10

VC's and PE

Venture capitalists and private equity funds are heavily involved in the North American medical cannabis market. How does this compare to Europe?
17:10-17:20

Going Public

IPO's are happening in Canada. Will the trend move to Europe?
17:20-17:30

Preventing Exploitation

In markets where medical cannabis is legal and recreational cannabis is not, what measures are in place to stop exploitation?
17:30-17:40

Commercialisation

Since medical cannabis isn't legal everywhere, advertising on social media and other digital platforms is limited. How might this effect an investor's decision on financing start-ups?
17:40-17:50

Traditional Financing Models

How is stigma and uncertainty preventing medical cannabis companies from raising capital from banks and lending institutions and how can this be addressed?
17:50-18:00

Supply and Demand

Cover supply is a problem affecting certain markets. How can a company accurately forecast demand?

Workshop Room

New Markets expand icon

TBA

Established Markets expand icon

TBA

Conference Room

Social Impact, Education & Europe

09:00-09:10

Medical Cannabis in the Maltese Public Sector

Hon. Chris Fearne

09:10-09:30

Patient-led Change

How did Hannah Deacon push for legislative change in the UK and what has been the outcome of her efforts?

Hannah Deacon

Mike Barnes

09:30-09:50

Educating the Public on Medical Cannabis

What sort of public awareness campaigns are needed to destigmatize cannabis and give appropriate information on the options available.
09:50-10:00

Social Impact in North America

What can North American sociological research on the affects of medical cannabis teach European countries?

Maya Elisabeth

Alix Hadley

Mark Braunstein

Anthony Bailey

10:00-10:10

Corporate Social Responsibility in the Medical Cannabis Industry

Environmental sustainability, social impact and good governance.

Steven Fish

10:10-10:20

Educating Medical Professionals

What are the most effective ways of educating the medical community on cannabis?

Richard Skaife

10:20-10:30

Demographic Landscape

Which demographics should be considered when looking at the uptake and acceptance of medical cannabis?

Gregor Zorn

10:30-10:50

Homegrown Medical Cannabis

The argument for and against regulation of private medical cannabis cultivation for patients taking it for long-term pain management.
10:50-11:00

Between Regulation and Education

How can commercial distributors of medicinal cannabis products educate patients without prescribing? What assistance are the medical authorities providing?

Andrew Agius

11:00-11:20

Marketing and Advertising

Strict regulations are influencing how medical cannabis is marketed. What measures do companies need to take when advertising their products? How will this affect the commercial viability of a business?

Richard Sharp

Alex Shah

11:20-11:30

Europe-wide Legislation

What initiatives are in place for the harmonization of medical cannabis laws across Europe?
11:30-11:50

Battle of the Jurisdiction

In this animated discussion, legal experts from various jurisdictions will go head to head in explaining which state is leading the way with regulatory innovation.

Joe Rogoway

11:50-12:00

Investors and Society

As investment firms look for more socially responsible projects to put their money, how is the medical cannabis industry benefiting?

Amber Senter

12:00-12:10

The Growth of the European Market

What advantages does Europe have for the development of this embryonic industry.
12:10-12:20

Conservatism

What can other countries learn from Germany's struggle with conservative medical professionals and their hesitance to subscribe?
12:20-12:30

Long Term Effects

There's a lot of debate around the potential negative effects on health of long-term medical cannabis use. How valid is this argument?

Technology & Security

14:00-14:10

The Advantages of Blockchain Technolog

How will blockchain disrupt this sector and help it to become more lucrative and competitive.

Aviya Arika

14:10-14:20

From Cultivation to Waste Disposal

How is Malta enforcing regulatory procedures?
14:20-14:30

Artificial Intelligence

What are the advantages of using A.I. to predict the size of a producer’s yield and is it financially viable in European markets?
14:30-14:40

Science and Technology

How is cutting edge equipment involved in analytical testing and quality control creating the future of the industry?
14:40-15:00

Bridging the Gap

How is innovative software narrowing the gap between doctor, patient and supplier?

Izidor Mutnica

15:00-15:10

Large Scale Cultivation & Extraction

What are the best practices for the design, build and marketing of cultivation and extraction facilities in Israel, US and Canada?

Adam Shuster

15:10-15:20

Greenhouse Climate Management

Managing the climate of a greenhouse, specifically the humidity and how it interplays with temperature, energy consumption, plant growth, disease prevention, and uniformity.

Yanor Yazma

15:20-15:30

Solar Energy

How Malta's medical cannabis industry can benefit from going solar.
15:30-15:40

Security Concerns

What can Malta learn about security from international growers

Yosi Sherman

15:40-16:00

Public and Private Health Cover

How are both the public and private healthcare sectors meeting the insurance requirements of medical cannabis patients. What issues do they face?
15:40-16:00

Solar Energy

How Malta's medical cannabis industry can benefit from going solar.
16:00-16:10

Data Protection

Due to the stigma still associated with cannabis, many patients worry about data protection. Which technologies are being used to but their minds at rest?
16:10-16:20

Secure Transportation

What considerations need to be made for the secure transport of crops and finished products within Malta?
16:20-16:30

The Local Corporate Insurance Industry

How is the local insurance industry involved with cannabis cultivation facilties, laboratories and retailers?
16:30-16:40

Law Enforcement

The medical cannabis industry is complex. To distinguish between legality and illegality in different parts of the supply chain is important for law enforcement officials. How are they being educated and trained in this area? What can Malta learn from other European countries?
16:40-17:00

Extraction Equipment

The complex process of extraction requires cutting edge technology and highly-trained professionals. What are the financial and recruitment implications of setting up an extraction facility?
17:00-17:10

Evaluating Medical Cannabis Dispensary Policies

How will this differ in Malta? What is the financial viability of making the required changes?
17:10-17:20

Ecological Innovation

How is Italy cultivating cannabis crops with an environmental focus?
17:20-17:40

Genetics

How is genetic testing and modification being used to maximise crop yields for medical cannabis? What effects, if any, is this having on the public perception that plant-based medicines should be 'natural'?
17:40-17:50

Automation

Smart systems are making headway in agricultural and horticultural spheres. How are they changing the game for medical cannabis growers?
17:50-18:00

Nano-Cannabinoid Technology

What are the pros and cons of this new technology?

Workshop Room

Start-Up Business Workshop with BDO expand icon

Hosted by:

TBA

Facilitating Taxation & Transparency with Blockchain Technology expand icon

TBA

ARE YOU A START-UP?
Fill in the Cannabiz
Start-Up Pitch
application form.
APPLY TODAY!
BECOME A SPEAKER
We’re always looking to collaborate
with thought leaders who are willing to shape the
medical cannabis industry.
SUBMIT
BOOK PASS TODAY!
Grab a ticket!
Low fees for all delegates.
Find out now.
BOOK YOUR PASS!